Boundless Bio, Inc.
NASDAQ:BOLDBiotechnology
+$1.20 today
- Market cap
- $56.20M
- Beta
- 0.97
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$2.50
Volume 0.13M
Average 0.22M
Returns on capital
Boundless Bio, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-59.0%
avg -9.7%
ROIC
-43.0%
avg -42.9%
ROA
-37.1%
avg -38.6%
Analysis
ROA is currently the strongest return metric at -37.1% versus its period average of -38.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
David Hinkle | Senior Vice President of Finance, Controller & Corporate Treasurer | — | 64 | — | — |
Jessica Oien | President, Principal Executive Officer, Chief Legal Officer & Corporate Secretary | — | 55 | 220.00K | 0.98% |
Meredith Wesley | Chief Human Resources Officer | — | — | — | — |
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jan 23, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
35
$1.97M
Sells
3
$134,031.00
Net Transaction Value
+$1.84M
Net buying
Most Active
TANG KEVIN
36 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Nov 10, 26Nov 10, 2026 | TANG KEVIN Indirect | Buy | $597.6$597.60 |
| Nov 6, 26Nov 6, 2026 | TANG KEVIN Indirect | Buy | $4.1K$4,080.00 |
| Nov 5, 26Nov 5, 2026 | TANG KEVIN Indirect | Buy | $20.1K$20,136.00 |
| Nov 4, 26Nov 4, 2026 | TANG KEVIN Indirect | Buy | $1.2K$1,240.80 |
| Nov 3, 26Nov 3, 2026 | TANG KEVIN Indirect | Buy | $5.4K$5,412.00 |
| Oct 27, 26Oct 27, 2026 | TANG KEVIN Indirect | Buy | $25.7K$25,696.80 |
| Oct 26, 26Oct 26, 2026 | TANG KEVIN Indirect | Buy | $22.9K$22,862.28 |
| Oct 23, 26Oct 23, 2026 | TANG KEVIN Indirect | Buy | $14.8K$14,836.92 |
| Oct 22, 26Oct 22, 2026 | TANG KEVIN Indirect | Buy | $13.9K$13,920.00 |
| Oct 20, 26Oct 20, 2026 | TANG KEVIN Indirect | Buy | $521.4$521.40 |
1–10 of 38
Summary
Insiders reported 35 buys worth $1.97M and 3 sells worth $134,031.00 over the last 12 months. That adds up to net buying of $1.84M. TANG KEVIN was the most active insider with 36 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A0 analysts |
| Net Income | N/A | N/A | N/A | N/A0 analysts |
| EBIT | N/A | N/A | N/A | N/A0 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Who does Boundless Bio, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about BOLD's management, answered from reported figures.
Who manages BOLD?
Boundless Bio, Inc. (BOLD) lists 3 active executives. The top listed executive is David Hinkle, Senior Vice President of Finance, Controller & Corporate Treasurer.
Are BOLD insiders buying or selling?
Recent insider activity shows net buying of $22.44M.
Continue the stock analysis
Jump to another research area for this company.